Changes in maternal plasma levels of VEGF, bFGF,TGF-β1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes

In Vivo

Volumn 20, Issue 1, 2006, Pages 157-164

  Lygnos, M C ^a   Pappa, K I ^a,c   Papadaki, H A ^b   Relakis, C ^a   Koumantakis, E ^a   Anagnou, N P ^c   Eliopoulos, George D ^b,d  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d NONE   (Greece)

Author keywords

Basic fibroblast growth factor; Endothelin 1; Soluble c kit ligand; Stem cell factor; Transforming growth factor 1; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; ENDOTHELIN 1; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; DIET THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

EID: 30844459673     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aydin S, Benian A, Madazli R et al: Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with pre-eclampsia. Eur J Obstet Gynecol Reproduct Biol 113: 21-25, 2004
2. Khedun SM, Naicker T and Moodley J: Endothelin-1 activity in pregnancy. J Obstet Gynaecol 22: 590-593, 2002.
3. Madazli R, Aydin S, Uludag S, Vildan O and Tolun N: Maternal plasma levels of cytokines in normal and preeclampsic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 82: 797-802, 2003.
4. 1 and epithelial-cadherin in pre-eclampsia. Obstet Gynecol 1090: 327-331, 2002.
5. Savas A, Ince S, Coskun M, Durmaz S and Yegin O: Stem cell factor (SCF) levels in newborns. Am J Perinatol 15: 427-429, 1998.
6. Tjwa M, Luttun A, Autiero M and Carmeliet P: VEGF and PIGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res 314: 5-14, 2003.
7. Granato A-M, Nanni O, Falcini F et al: Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools? Breast Cancer Res 6: R38-R45, 2004.
8. Roberts AB: Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24: 111-119, 1988.
9. Bobik A, Grooms A, Milar JA, Mitchel A and Grinpukel S: Growth factor activity of endothelin on vascular smooth muscles. Am J Physiol 258: 408-415, 1990.
10. Yanagisawa M, Kurihara H, Kimura S et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
11. Lyman SD and Jacobsen SEW: C-kit ligand and flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91: 1101-1134, 1998.
12. Kupferminc MJ, Daniel Y, Englender T et al: Vascular endothelial growth factor is increased in patients with pre-eclampsia. Am J Reprod Immunol 38: 302-306, 1997.
13. Sharkey AM, Cooper JC, Bahnforth JR et al: Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 26: 1182-1185, 1996.
14. Bosio PM, Wheeler T, Anthony F, Conroy R, O'Herlihy C and McKenna P: Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationships to peripherial vascular resistance. Am J Obstet Gynecol 184: 146-152, 2001.
15. Kurz C, Hefler L, Zeisler H, Schatten C, Hussein P and Tempfer C: Maternal basic fibroblast growth factor serum levels are associated with pregnancy induced hypertension. J Soc Gynecol Invest 8: 24-26, 2001.
16. Hill DJ, Flyvbjerg A, Arany E, Lauszus FF and Klebe JG: Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women in retinopathy. J Clin Endocrinol Metab 82: 1452-1457, 1997.
17. 1 serum levels. J Clin Endocrinol Metab 88: 1280-1284, 2003.
18. Ogasawara MS, Aoki K, Aoyama T et al: Elevation of transforming growth factor-beta, is associated with recurrent miscarriage. J Clin Immunol 20: 453-457, 2000.
19. 1, and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta 23: 380-385, 2002.
20. Ohno Y, Mizutani S, Kurauchi O, Nishida Y, Arri Y and Tomoda Y: Umbilical plasma concentration of endothelin-1 in interpartum fetal stress: effect of fetal heart rate abnormalities. Obstet Gynecol 86: 822-825, 1995.
21. Bussen S, Sutterlin M and Steck T: Plasma endothelin and big endothelin levels in women with pre-eclampsia or HELLP syndrome. Arch Gynecol Obstet 262: 113-119, 1999.
22. Hammadeh ME, Fischer-Hammadeh C, Hoffmeister H, Herrmann W, Rosenbaum P and Schmidt W: Relationships between cytokine concentrations (FGF, sICAM-1 and SCF) in serum, follicular fluid and ICSI outcome. Am J Reprod Immunol 51: 81-85, 2004.
23. Whitworth JA: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on the management of hypertension. J Hypertens 21: 1983-1992, 2003.
24. Carpenter MW and Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144: 168-173, 1982.
25. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nature Med 9: 669-676, 2003.
26. Veikkola T and Alitalo K: VEGFs, receptors and angiogenesis. Semin Cancer Biol 9: 211-220, 1999.
27. Pugh CW and Ratcliffe PJ: Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Med 9: 677-684, 2003.
28. Reynolds LP and Redmer DA: Angiogenesis in the placenta. Biol Reproduct 64: 1033-1040, 2001.